Sedil

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sedil

Property Description
Active ingredient Diazepam
Form Tablet, Solution, Rectal gel
Pharmacological class Benzodiazepine / CNS Depressant
General purpose Anxiolytic, Muscle Relaxant, Anticonvulsant
Origin Synthetic chemical compound

What Type of Medicine is Sedil?

Sedil is a commercial name for the active pharmaceutical ingredient Diazepam, which is chemically defined as a Benzodiazepine Derivative and classified as a Central Nervous System (CNS) Depressant. This synthetic compound is clinically recognized for its efficacy across various neurological conditions. Diazepam is recognized for its importance in global health systems. Its classification places it within the major group of anxiolytics, sedatives, and anticonvulsants.

The pharmacological class of Benzodiazepines is characterized by their ability to enhance the effects of the inhibitory neurotransmitter, Gamma-aminobutyric acid (GABA). This reliance on the natural calming mechanism in the brain is key to the drug’s function, facilitating a greater state of inhibition; this serves as the mechanism of action for this long-acting agent. The long-lasting profile of Diazepam differentiates it from short-acting agents, making it well-suited for managing sustained conditions.

Composition, Forms, and General Purpose

The medication is a single-ingredient product, with Diazepam serving as the only active therapeutic compound. It is prepared for oral administration as a tablet or solution, and also as a sterile injection solution or rectal gel for parenteral and rectal routes of administration. The availability of the rectal gel formulation is a distinctive feature reflecting its utility in acute, time-sensitive situations.

The diverse dosage forms allow for flexibility in application, targeting the drug's core general purpose: to relieve symptoms stemming from heightened CNS activity. The medication is indicated as a centrally acting skeletal muscle relaxant and for the treatment of anxiety. The medicine is useful for promoting physical relaxation and easing states of worry, playing a role in managing acute tension states. The primary benefit is the restoration of chemical balance to promote calmness and physical relaxation.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Sedil?

Sedil, which belongs to the benzodiazepine class of medicines, carries specific safety information mandated by regulatory authorities, focusing primarily on the risks of dependence, withdrawal, and interactions with other central nervous system (CNS) depressants.

Serious and Clinically Significant Risks

The most serious safety concerns for Sedil are formally documented as a Boxed Warning that highlights:

  • Dependence, Abuse, and Misuse: Sedil use, even as prescribed and for short durations (several days to weeks), can lead to physical dependence. Misuse and abuse can result in overdose or death, particularly when the drug is combined with other substances like opioids or alcohol.
  • Life-Threatening Respiratory Depression: Concomitant use with opioids or other CNS depressants may result in profound sedation, severe respiratory depression, coma, and death.
  • Withdrawal Reactions: Abrupt discontinuation or rapid dosage reduction can precipitate severe and potentially life-threatening withdrawal symptoms, including seizures, tremors, and severe anxiety. A gradual tapering schedule is required when discontinuing the drug.

Common Adverse Reactions

The most frequently reported side effects are generally related to the drug's action on the central nervous system. These may include drowsiness, fatigue, confusion, dizziness, impaired coordination (ataxia), and muscle weakness.

Population-Specific Safety Considerations

  • Pregnancy and Lactation: Sedil is generally considered unsafe for use during the first trimester of pregnancy due to the potential risk of congenital malformations. Use late in pregnancy may be associated with neonatal flaccidity and respiratory difficulties. The drug passes into breast milk, and use during lactation is typically discouraged or requires careful monitoring of the infant.
  • Elderly and Debilitated Patients: These populations are typically more sensitive to the sedative and respiratory depressant effects. A lower starting dose and close monitoring are usually advised.
  • Patients with Hepatic or Renal Impairment: Caution is required as clearance of Sedil may be reduced, increasing the risk of accumulation and side effects. Sedil is often contraindicated in severe liver disease.

Overdose and Emergency Response

Sedil (Diazepam) overdose primarily involves an intensification of its documented Central Nervous System (CNS) depressant effects. Manifestations range from common symptoms such as drowsiness, confusion, lethargy, and slurred speech to more severe signs, including ataxia (impaired coordination), diminished reflexes, and hypotension (low blood pressure).

Overdosage may progress to severe and potentially life-threatening outcomes, including profound sedation, respiratory depression, coma, and death. Regulatory information notes this risk is significantly increased when the medication is co-ingested with other CNS depressants, such as alcohol or opioids. Patients in vulnerable groups, including the elderly and those with impaired liver function, are documented to be at increased risk of severe adverse effects due to potential drug accumulation.

Regulatory guidance mandates that immediate medical help must be sought if an overdose is suspected. Urgent medical attention is required if the person has collapsed, has trouble breathing (or slow/shallow breathing), or cannot be awakened. Official management protocols prioritize symptomatic and supportive care, focusing on maintaining a patent airway and monitoring vital functions. The benzodiazepine antagonist Flumazenil is a documented therapeutic option, although its use requires careful clinical evaluation.

Therapeutic Uses of Sedil

What Sedil Treats: Main Uses and Benefits

Sedil (Diazepam) is commonly used in clinical settings marked by heightened physiological or emotional tension, offering symptomatic relief that helps patients cope more steadily with difficult episodes across three main therapeutic domains. The medication's applications include various indications, such as anxiety, muscle spasm, and seizure disorders.

The medication is commonly used to help manage symptom clusters associated with severe, disabling anxiety and other forms of acute tension. It is relevant for easing acute painful muscle spasms and sustained muscle stiffness (spasticity), and is applied in addressing severe recurrent convulsive seizures.

“The primary benefit of this medication is its ability to help ease the overall symptom burden when distress and physical tension become intense or disruptive.”

This support is helpful in scenarios where symptoms become temporarily overwhelming, and is relevant in contexts involving heightened systemic burden. When symptoms are related to heightened physiological activity, the medication contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

Quick Fact: Symptomatic support for Acute Tension States

Eligibility and Restrictions for Use

Official Eligibility Profile for Sedil

The eligibility for Sedil (Diazepam) is strictly defined by regulatory documents, which list specific patient populations who are permitted to use the medicine, who must not use it (contraindicated), and who require conditional use.

Contraindicated Populations

Sedil must not be used in patients with [1.2, 3.1]:

  • Known hypersensitivity to Diazepam or other benzodiazepines.
  • Myasthenia Gravis (a neuromuscular disease).
  • Severe Respiratory Insufficiency or Sleep Apnoea Syndrome.
  • Severe Hepatic Insufficiency or Severe Liver Failure.
  • Acute Narrow-Angle Glaucoma.

Age-Based Eligibility and Restrictions

Age Group Eligibility Status (Oral/Injection) Conditional Status
Adults Allowed Standard use [1.3]
Older Adults (65+) Eligible Requires special care; a lower dose is recommended [2.1]
Children 6 months of age and older Safety and efficacy have not been established in patients under 6 months [3.1]

Condition-Specific Limitations

Use is restricted or conditional in other populations [2.1, 3.1, 3.3]:

  • Chronic Respiratory Insufficiency: A lower dose is recommended due to respiratory risk.
  • Mild to Moderate Hepatic Impairment: Requires caution and likely a reduced dose.
  • Pregnancy: Use is generally not recommended; benefits must be weighed against risks to the fetus [1.4].
  • Breastfeeding: Not recommended, as the drug and its metabolites pass into breast milk [1.4].

Connection to the Overall Eligibility Profile

Regulatory authorities establish eligibility by mandating absolute contraindications for severe organ failure and specific co-morbidities [3.1]. For all other patients, eligibility is conditionally granted, requiring specific age minimums and caution, often requiring dose modification for older adults or those with organ impairment, as defined in the official labeling [2.1, 3.3].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Sedil (Diazepam) around two primary mechanisms: pharmacodynamic reinforcement and metabolic inhibition.

Pharmacodynamic Interactions

The most significant pharmacodynamic interaction involves other Central Nervous System (CNS) Depressants. Co-administration with Opioids is classified in regulatory labeling as carrying a high risk of profound sedation and respiratory depression. The use of Alcohol (ethanol) is similarly not recommended due to the documented enhancement of the sedative and depressant effects. This cautionary domain extends to classes such as muscle relaxants, hypnotics, and sedative antihistamines.

Pharmacokinetic Interactions

Sedil is cleared primarily by the hepatic enzymes CYP3A4 and CYP2C19. Co-administration with known enzyme inhibitors, such as Omeprazole, Cimetidine, Fluoxetine, and certain antifungals, is officially documented to increase Sedil exposure and may prolong sedation due to reduced metabolic clearance. Conversely, Sedil may also decrease the metabolic elimination of other medicines, including Phenytoin.

Food, Substance, and Population Notes

Interactions are documented with certain substances and foods: Grapefruit juice is noted to increase the drug's plasma levels. Administration with a moderate fat meal or Antacids may slow the rate of absorption, leading to a lower peak concentration. Furthermore, official information includes cautions regarding Population-Specific risks: decreased drug clearance in patients with hepatic impairment and the potential for metabolite accumulation in elderly patients with reduced renal function are explicitly noted.

Mechanism of Action

Modulation of GABAergic Inhibitory Signaling

Sedil's primary mechanism involves its function as a Positive Allosteric Modulator (PAM) of the extbfGABA-A extbfreceptor, a ligand-gated ion channel abundant throughout the Central Nervous System (CNS). Sedil binds to an allosteric site on the receptor, separate from the site where the endogenous neurotransmitter GABA binds. This interaction facilitates a change in the receptor's conformation, increasing the affinity or efficacy of GABA. Consequently, the chloride ion channel opening frequency and duration are enhanced, driving an increased influx of chloride ions ( Cl^-) into the neuron.

Central Nervous System Pathway Amplification

The resulting influx of negative ions hyperpolarizes the postsynaptic membrane, which increases the neuron's threshold for excitation. This widespread amplification of GABAergic inhibitory signaling across the CNS, particularly in areas regulating muscle tone and arousal, leads to a significant reduction in overall neural excitability and firing rates. The downstream physiological consequences of this CNS depression include sedation and myorelaxation (decreased skeletal muscle motor neuron activity), which define the drug's core functional effects.

Dosage and Administration Information

The medicine branded as Sedil contains the active substance diazepam, a benzodiazepine. The following instructions for use describe the protocol for the active ingredient.

Administration Scope

Usage Parameter Administration Parameters
Route of Administration Oral (Tablet) or Intravenous/Intramuscular (Injection)
Dosing Schedule Individualized based on the condition being addressed. Typical oral doses for adults range from 2 mg to 10 mg, administered two to four times daily.
Timing in Relation to Meals Oral tablets may be taken with or without food. However, administration with a moderate-fat meal may delay and decrease the rate of absorption.
Preparation Requirements Injectable forms require careful, slow administration, taking at least one minute for every 5 mg (1 mL) of the solution injected intravenously. The injectable solution should not be mixed or diluted with other solutions in a syringe or infusion container.
Age-Group Administration Lower doses, typically 2 mg to 5 mg, are used for elderly and debilitated patients. Oral use is generally contraindicated in pediatric patients under 6 months of age.
Missed-Dose Rules Missing a dose or stopping treatment abruptly is associated with withdrawal symptoms; therefore, the prescription requires strict adherence to the prescribed regimen.

Procedural Structure

The full procedure for administration is defined by the specific dosage form and route:

  • Oral: Swallow the tablet whole with liquid at the prescribed frequency.
  • Intravenous/Intramuscular: Injection must be administered slowly by a healthcare provider, especially in the case of intravenous use, to reduce the risk of local irritation and potential adverse cardiovascular effects.

Connection to the Overall Use Protocol

These instructions define the approach to using the medicine. The administration rules dictate the precise quantity, frequency, and method of taking the drug to maintain consistent levels of the active substance in the body, without addressing the specific effects or benefits of the medicine.

Recent Clinical Evidence

Research Evidence Overview for Sedil (Diazepam)

This section summarizes the official research evidence concerning the clinical evaluation of Sedil (Diazepam), focusing on the types of studies conducted, the outcomes they monitored, and the areas where data remains limited or uncertain. This information is purely descriptive and does not offer clinical advice or instruction.


Evidence from Studies for Acute Anxiety and Tension

Sedil was evaluated in research exploring how symptoms change over time using short-term, randomized controlled trials (RCTs) and systematic reviews. These studies explored outcomes related to systemic or functional imbalance by monitoring standardized anxiety rating scales and patient-reported outcomes describing perceived discomfort. Findings from these short-term studies describe patterns observed in the studies related to outcomes describing episodic or acute changes. Comparative evidence also was evaluated in studies against other agents studied for this purpose. Long-term effects are not fully established for sustained use, as follow-up durations were limited.

Research Findings for Acute Seizure Management

The research examined Sedil in conditions associated with acute or disruptive episodes, such as severe recurrent convulsive seizures, and was observed in a structure of RCTs and meta-analyses. Studies monitored outcomes capturing phases of heightened symptom activity, such as the time to seizure cessation and the rate of seizure termination following administration. The data show patterns related to timing of outcome measurement, as monitored in acute research scenarios. Studies describe an observation that a tolerance may be observed over time to the anticonvulsant effects, contributing to the limited nature of long-term use.


What Scientific Research Remains Uncertain

Official research documentation identifies key limitations in the evidence base. This includes a limited information for long-term outcomes across all indications, as trials rarely monitored patients beyond a few weeks or months. Studies also describe that tolerance development may cause certain effects (anticonvulsant and muscle relaxant) to diminish over time. Additionally, subgroup findings are uncertain, as detailed research data for specific populations, such as patients with certain comorbidities, remain insufficient.

Key Studies & References

  1. Public Assessment Report: Scientific discussion Diazepam Stada 2 mg, 5 mg and 10 mg tablets (European regulatory document)
  2. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan
  3. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials

Frequently Asked Questions (FAQ)

Common questions about Sedil (FAQ)

Q: Can Sedil be taken with high blood pressure medication?

Regulatory documents describe that Sedil may have additive effects when taken alongside certain medicines used for high blood pressure. This combination may be associated with an increased potential for side effects, such as dizziness, lightheadedness, or changes in heart rate. Official documents advise that caution and monitoring may be necessary for these enhanced effects.

Q: Can I take Sedil if I am pregnant?

Official information indicates that Sedil should generally not be used during pregnancy unless the potential benefit is judged to outweigh the possible risks to the fetus. The decision to use Sedil during pregnancy involves a careful assessment of potential benefits versus risks, as outlined in the official prescribing information. The drug is associated with potential risks during the first trimester and may cause withdrawal symptoms in the newborn if used late in pregnancy.

Q: Is Sedil safe to take while breastfeeding?

Use of Sedil while breastfeeding is generally not recommended in official guidelines. The active substance and its metabolites are known to pass into breast milk. Official guidance states that nursing infants should be closely monitored for adverse effects such as increased sedation, difficulty feeding, or weight loss.

Q: Does Sedil have a black box warning from the FDA?

The regulatory documents for Sedil, including those from the U.S. FDA, contain a Boxed Warning. This is the agency’s strictest safety alert, highlighting serious risks. The warning emphasizes the danger of severe sedation and breathing difficulties when Sedil is combined with opioids, and the serious risks of dependence, abuse, misuse, and severe withdrawal reactions.

Q: Do studies suggest Sedil is effective?

Sedil is approved by regulatory agencies for specific medical purposes, including the management of anxiety, muscle spasms, and certain acute seizures. Official product information indicates that its intended use is supported by systematic clinical studies for these approved indications, though long-term efficacy has not been fully established.

Q: Does Sedil contain lactose or gluten?

The tablet formulations of Sedil (Diazepam) commonly list anhydrous lactose as one of the inactive ingredients in their regulatory labeling. Information regarding the presence of gluten in the medication is generally not provided in the official drug label.

Q: Is Sedil used for short-term or long-term issues?

Regulatory documents recommend that Sedil be used for the shortest duration necessary to manage acute symptoms. This recommendation is due to the potential for dependence and withdrawal symptoms with prolonged use, as systematic studies have not fully assessed its effectiveness for sustained use beyond a few months.

Q: How quickly does Sedil typically start to work?

Following oral administration, official documents indicate that Sedil typically has an onset of action ranging between 15 to 60 minutes. When administered intravenously (by injection), the reported onset is very rapid, often occurring within 1 to 3 minutes.

Q: How long do the effects of Sedil last?

Sedil is characterized as a long-acting agent, with the duration of its clinical effects determined by its prolonged half-life. Official information states that the active substance itself has an average elimination half-life of approximately 48 hours, and its active metabolite can remain in the body even longer (up to 100 hours).

Q: Why do some people say Sedil makes them feel foggy?

Sedil works by reducing overall neural activity in the brain. Regulatory documents list common side effects that include drowsiness, confusion, and dizziness. These known effects on the central nervous system may be what patients are describing when they report feeling a mental fog or reduced mental clarity.

Q: Can Sedil cause issues with sleeping?

While Sedil is a CNS depressant known to cause drowsiness, regulatory documents also list less common, opposite reactions (paradoxical effects). These paradoxical reactions may include side effects such as insomnia and other sleep disturbances.

Q: Are there any major diet restrictions while using Sedil?

Official information specifically mentions an interaction with grapefruit juice, which can lead to higher levels of the drug in the body. Furthermore, taking Sedil with a moderate fat meal may slow down how quickly the drug is absorbed, potentially reducing its peak concentration.

Q: Is it normal to feel a bit restless after taking Sedil?

Regulatory documents list a range of possible effects on the central nervous system. Although the drug is generally calming, in rare instances, certain paradoxical reactions have been reported in official labeling. These unusual reactions include feelings of agitation, anxiety, and restlessness.

Q: Does Sedil cause weight gain?

Official information does not typically list weight gain as one of the common or serious adverse reactions. However, regulatory documents from some countries state that Sedil may, rarely, be associated with changes to a patient’s appetite.

Q: Can Sedil affect your ability to drive or operate machinery?

Official safety precautions advise that Sedil may cause drowsiness, dizziness, impaired coordination, or confusion. Official safety precautions describe a potential risk when engaging in activities that demand complete mental alertness, such as driving or operating machinery, until an individual knows how the medicine affects them.

Q: How long does Sedil stay in your system?

Sedil is cleared slowly, having a prolonged terminal elimination half-life of approximately 48 hours. Its primary active metabolite, which also has effects, has an even longer half-life that can be up to 100 hours. The duration the drug and its metabolites remain in the system is considered extended.

How should Sedil be stored and disposed of?

Sedil (Diazepam) must be stored and disposed of according to strict regulatory guidelines due to its classification as a controlled substance.

Storage Conditions

The oral solution is required to be stored at Controlled Room Temperature (20 C to 25 C) and protected from light. The container must be kept tightly closed and away from freezing. All forms of the medicine must be stored out of the sight and reach of children in a secure location.

Stability and Disposal

The opened oral solution must be discarded after 90 days. When disposing of unused or expired Sedil, do not flush it down the toilet or pour it down the sink. The drug must be taken to an authorized drug take-back program. If a program is unavailable, mix the drug with an undesirable substance (e.g., dirt) in a sealed bag before placing it in the trash, and scratch out all personal information on the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sedil found in:

A-Z Index: